Recipient of federal assistance · AURORA, CO

TRAMPOLINE PHARMA, INC.

TRAMPOLINE PHARMA, INC. received $398K in federal grants and other assistance in FY2026, on 2 actions. It has no federal contracts in the loaded years. Since FY2022: $2.4M. Its largest awarding agency was National Institutes of Health ($398K).

Assistance · FY2026
$398K
New awards
1
Actions
2
Since FY2022
$2.4M
UEI
QAE3GETX9Z88
Location
AURORA, CO
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 1MFY2022
  2. 1MFY2023
  3. 0FY2024
  4. 398KFY2026

By type

  1. Grants$398K100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.395 · Cancer Treatment Research$398K100%

Awarding agencies

  1. National Institutes of Health$398K100%
    Department of Health and Human Services

Largest awards

  1. NEXT GENERATION AUTOLOGOUS TIL CANCER THERAPY: DEVELOPMENT OF GMP MANUFACTURING PROCESS - THE OVERALL GOAL OF THIS PHASE II SBIR GRANT…$2M
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Aug 17, 2022 – Jan 20, 2026· R44CA268313
  2. DEVELOPMENT OF A UNIVERSAL NEXT GENERATION T CELL RECEPTOR CANCER THERAPY: PRECLINICAL PROOF-OF-CONCEPT AND OPTIMIZATION - THE OVERALL GOAL…$398K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Sep 10, 2026 – Sep 10, 2026· R43CA310292

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 8, 2026, loaded Oct 8, 2026 · FY2022–FY2026.